Everyday Health on MSN

Blockbuster Cancer Drug Keytruda Now Available as a Time-Saving Shot

Patients taking the immunotherapy drug Keytruda (pembrolizumab) may now have the option to take it as a quick shot instead of ...
KTVU FOX 2 on MSN

Universal cancer vaccine could be coming, researchers say

Scientists have conducted breakthrough research that could lead to a universal cancer vaccine, revolutionizing how the ...
Earth.com

New study shows how cancer tricks the immune system with the help of a hormone

The SCG2 hormone allows tumors to suppress immune defenses, opening up a new therapeutic avenue against cancer.

HCW Biologics Designates One of Its Proprietary TRBC-Pembrolizumab-Based Immune Checkpoint Inhibitors as its Franchise Immunotherapeutic for Internal Clinical Development

Lead product candidate will be advanced to late IND-enabling studies to prepare for clinical trials for evaluation in the treatment of solid ...
Seeking Alpha

HCW Biologics to Showcase its Novel Second-Generation Immune Checkpoint Inhibitor Identified as a Potential Gateway to a Multi-Billion Dollar Market

MIRAMAR, Fla., Aug. 25, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (HCWB), a U.S.-based clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to ...
UroToday

SCS AUA 2025: Efficacy and Safety of Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Combination Regimen in Metastatic RCC

The immune checkpoint inhibitor combination regimen has become the initial standard of care for metastatic RCC, given its ...

Marengo to Present a Late-breaking Clinical Oral Abstract at ESMO 2025 on Initial Phase 2 Clinical Data of Invikafusp Monotherapy Activity in Patients with Antigen-Rich Solid ...

Marengo Therapeutics, Inc., a clinical-stage biotechnology company pioneering novel approaches for precision immunotherapy in oncology and inflammation and immunology (I&I), will present a ...
ascopubs.org

Clinical Characteristics of Toxicities of Immune Checkpoint Inhibitors and Their Impact on Efficacy in Solid Cancers: An Analysis of Real-World Data in Moroccan Patients

We conducted a prospective study of patients with solid tumors who received pembrolizumab or atezolizumab at the National Institute of Oncology, Rabat from July 2018 to December 2023. We identified ...